NL-OMON40083
Completed
Not Applicable
Diagnostic criteria for Multiple Sclerosis: Impact of high field Magnetic Resonance Imaging - 3T-CIS Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- MS
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •CIS suggestive of MS as defined by the International Panel
- •Age 18\-59 years
Exclusion Criteria
- •Vascular, malignant or other immunological diseases at present or in the past medical history;MRI related exclusion criteria:
- •\- Claustrophobia
- •\- Foreign non MR compatible metal objects in the body
- •\- Foreign metal objects in or close to the head
- •\- Allergic reaction to contrast administration in the past (only for patients)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Characterisation of multiple sclerosis pathology by ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques[Charakterisierung der Multiple Sklerose Pathologie durch ultra small particles of iron oxide (USPIO)” im Vergleich zu konventionellen und fortgeschrittenen MRT Techniken] - MS_USPIO_MPIPPatients with Multiple Sclerosis (MS, N=90) and patients with a clinically isolated syndrome (ref. to as CIS in literature, i. e. not a clinically definite MS but a syndrome that may occur as first sign of MS early in the course, N=15) are planned to be investigated in the proposed clinical trial.MedDRA version: 8.1Level: LLTClassification code 10028245Term: Multiple sclerosisEUCTR2006-001337-17-DEMax-Planck-Institute of Psychiatry
Completed
Not Applicable
Multiple sclerosis lesion characterization on ultra-high-field MRI: Comparative pilot study of 9.4 vs 7 vs 3 teslaMSmultiple sclerosis10012303NL-OMON52035Zuyderland Medisch Centrum10
Recruiting
Phase 3
Patients with Multiple Sclerosis and Severe Disabilities: Effects of Electrical Stimulation Cycling Training on Mobility an Power PerformanceG35.2R26.3ImmobilityDRKS00011639Zentrum für Sensomotorik der Neurologischen Klinik,Klinikum Großhadern64
Completed
Phase 3
A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MSMultiple SclerosisSpasticity, MuscleNCT03290131RVL Pharmaceuticals, Inc.536
Active, not recruiting
Phase 3
Multiple Sclerosis-Simvastatin Trial 2Secondary Progressive Multiple Sclerosis (SPMS)NCT03387670University College, London964